Filing Flows › Rapid Micro Biosystems (RPID) › Q1 2025
Rapid Micro Biosystems (RPID) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 9, 2025
Rapid Micro Biosystems (RPID) reported revenue of $7.2M for the first quarter 2025 (Q1 2025), +28% from a year earlier and -12% from the quarter before. Operating margin was -161.8%, net loss $11.3M (156.3% of revenue).
Rapid Micro Biosystems, Q1 2025: revenue $7.2M (+28% year over year), operating margin -161.8%, net loss $11.3M, operating cash flow −$9.1M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $7.2M | -12% | +28% |
| Operating profit | −$11.7M | — | — |
| Net earnings | −$11.3M | — | — |
| Operating cash flow | −$9.1M | — | — |
What changed
Revenue was $7.2M in Q1 2025, up 28% year over year and down 12% from the previous quarter. Product was the largest line at 57% of revenue. Service added $1.2M year over year (up 64%), 76% of the total change.
Gross margin was 5.6%. Operating costs exceeded revenue by $11.7M, an operating margin of -161.8%. The quarter ended with a net loss of $11.3M, wider than the previous quarter's $9.7M loss.
Operating cash flow was −$9.1M. Non-cash charges added back $847K of depreciation and amortization and $1.0M of share-based compensation. Capital expenditures of $319K exceeded it, leaving free cash flow of −$9.4M.
Questions
What was Rapid Micro Biosystems' revenue in the first quarter 2025?
Rapid Micro Biosystems (RPID) reported revenue of $7.2M for the first quarter 2025 (Q1 2025), +28% from a year earlier and -12% from the quarter before.
Was Rapid Micro Biosystems profitable in the first quarter 2025?
Operating loss was $11.7M (-161.8% of revenue) and net loss $11.3M.